SAGEMCOM
14.9.2023 16:49:27 CEST | Business Wire | Press release
Sagemcom, a world leader in video, audio, and broadband solutions to operators, today announced that its newest version of its ground-breaking Video Soundbox™ is powered by RDK open-source software.
RDK is an open-source software solution, deployed on more than 100 million devices worldwide, that standardizes core functions and telemetry used in broadband, video, and IoT connected devices. Last year, Sagemcom announced that it became a member of the prestigious RDK Technical Advisory Board and its commitment to embed RDK software throughout its full portfolio of broadband CPE devices (PON, FTTH, DOCSIS, DSL and 5G). Sagemcom also is adopting RDK software within video products, including the Video Soundbox—an all-in-one audio/video entertainment hub, embedding premium speakers and woofer, Dolby Atmos and Dolby Vision certified, with powerful, natural and authentic audio fine-tuned by Bang & Olufsen.
“With the home entertainment market constantly evolving, Sagemcom is always looking for ways to bring innovative and high-quality products to its customers in the best ways possible,” said Olivier Taravel, Senior Executive Video President, Audio Video Solutions BU, Sagemcom. “Our commitment to RDK is foundational to our product roadmaps, and we’re excited to offer the Video Soundbox as the latest product available for RDK operators around the world. We’re also confident that the Video Soundbox is a true product differentiator that can help operators increase customer satisfaction with its high NPS and reduce churn.”
“Sagemcom remains at the forefront of product and service modernization for today’s pay TV and broadband service providers,” said Jason Briggs, RDK President and General Manager. “We’re honored to have them as members of our RDK Technical Advisory Board, and we are particularly pleased to see them adopt RDK into a device as innovative as their Video Soundbox.”
Video Soundbox
Whether watching a movie, streaming music, or just enjoying some background sounds, the Video Soundbox delivers an audio experience that can immerse consumers in their favorite content and bring it to life. Video Soundbox is Dolby Atmos and Dolby Vision certified, meaning it can deliver rich, spatialized sound and crystal clear 4K HDR pictures. This makes it the perfect choice for a home cinema setup, as it allows viewers to fully experience the depth and clarity of modern content.
The Video Soundbox also offers far-field voice control and voice assistance services through its embedded microphones. This makes it easy to use and convenient for multi-user and multi-language scenarios. With the Video Soundbox, consumers can change the volume, switch channels, or play their favorite playlist just by speaking a command.
One of the most compelling reasons for operators to consider deploying the Video Soundbox is its high net promoter score (NPS). This metric measures customer satisfaction and loyalty, and the Video Soundbox consistently shows consumers to be extremely satisfied, which makes it a great retention tool for operators.
For more information on Audio Video Solutions: contact-AVS@sagemcom.com
Additional information about RDK is available at www.rdkcentral.com.
About Sagemcom
Thanks to the innovative solutions designed and built by our people, Sagemcom provides access to broadband Internet, entertainment and managed energy supply to the greatest number all over the world.
As a “mission-driven company” since January 2022, Sagemcom makes sure that the design, construction and use of these solutions are sustainable, and fulfil the environmental and societal commitments that are known and shared by all our employees, partners and stakeholders. Sagemcom is the world leader in Broadband products and solutions, and the European leader in smart metering.
www.sagemcom.com // https://www.linkedin.com/company/sagemcom // www.facebook.com/SagemcomOfficial // https://twitter.com/Sagemcom // https://www.instagram.com/sagemcom_inside.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230915547929/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 18:19:00 CEST | Press release
FDA’s decision makes ZYN the first nicotine pouch product to receive MRTP orders authorizing reduced-risk claims versus cigarettes Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease
Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 17:00:00 CEST | Press release
Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border
Archer® Proves Purpose-Built AI Beats General-Purpose LLMs on Regulatory Change Management: 95% Verified Accuracy, 80x Faster, 92% Lower Cost30.6.2026 16:13:00 CEST | Press release
In a head-to-head benchmark, a leading general-purpose LLM was confidently wrong 35% of the time on regulatory dates. Archer Evolv™ shipped zero errors. For enterprises deploying AI in compliance, a wrong date is a missed deadline. The more dangerous failure is a wrong answer the model returns with high confidence, one that flows silently into a compliance calendar and is only discovered after the window has passed. Archer® today released results showing purpose-built AI beats a general-purpose large language model (LLM) on regulatory work, and it’s not close. This head-to-head test compared Archer’s purpose-built, vertical-specific AI and proprietary data sets against a leading general-purpose LLM, on a core compliance task: determining the publication, effective and comment-close dates of regulatory documents across six jurisdictions. General-purpose models are a genuine breakthrough, and this is no referendum on their quality. The question Archer set out to answer is narrower and mo
Altasciences Supports Key Development Milestone for Steel Therapeutics’ Lead Therapeutic Candidate, Fizurex™30.6.2026 16:08:00 CEST | Press release
Altasciences, a leading drug development organization, today announced a significant milestone in the development of Steel Therapeutics, Inc.’s pivotal toxicology study for its lead product candidate, Fizurex™, for the treatment of anal fissures. The successful completion of the study plays a significant role in the advancement of Fizurex™ toward first-in-human trials. The GLP-compliant study demonstrated a favorable safety profile, which has advanced Steel Therapeutics' plans to submit an Investigational New Drug (IND) application for Fizurex™ to the FDA in Q3 2026. Fizurex™, a patent-pending, single-use topical wipe, was designed to provide a standardized, accessible treatment option for a painful and often undertreated medical condition. The product builds on years of use through compounding pharmacy prescriptions and is now advancing toward clinical development and regulatory review. "We are proud to have supported Steel Therapeutics with the generation of the high-quality safety d
Interactive Brokers Expands Access to Korean Equities with Launch of Nextrade ATS30.6.2026 16:00:00 CEST | Press release
IB SmartRouting℠ Routes Orders to the Best Available Price Between KRX and Nextrade Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced the launch of select Korean equities through Nextrade, South Korea's first Alternative Trading System (ATS). The addition of Nextrade builds on Interactive Brokers' earlier launch of the Korea Exchange (KRX), through which it became the first major US-based broker to provide global investors with direct access to Korean equities. Clients trading on Nextrade benefit from significantly extended trading hours and access to additional liquidity. Interactive Brokers has enabled IB SmartRouting℠ across both the Korea Exchange (KRX) and Nextrade, automatically routing orders to the venue offering the best price. This helps clients achieve best execution while providing greater flexibility and more opportunities to participate in one of Asia's most dynamic equity markets. Korea's equity market ranks among the top global exchanges by
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom